News

Difluprednate ophthalmic emulsion 0.05% (Durezol, Sirion Therapeutics) was comparable with prednisolone ophthalmic suspension 1% (Pred Forte, Allergan), the current standard of care, in a pivotal anterior uveitis trial. Difluprednate was dosed four times daily compared with eight times for prednisolone acetate, suggesting that it could enhance compliance.

When capsulorrhexis becomes complicated by a radial tear, pulling the flap backward, first circumferentially and then centrally, can rescue the tear-out. Here, an ophthalmologist shares a technique to successfully address this complication.

Napa and Sonoma counties, located approximately an hour from San Francisco, are well known around the United States and the world for their superior wine and wineries. Here is just a sampling of the local vineyards.

San Francisco has cuisine to satisfy many taste buds. From dim sum to gnocchi, use this guide to map out your dining tour of the city by the bay.

San Francisco is nearly synonymous with a high cost of living. The advent and financial success of the early years of the Internet revolution still lures high-income folks to the city by the bay. Property values and household income are among the top in the nation, which enables a profitable restaurant and entertainment scene.

Soft Plug Flow Control Silicone Plugs (Oasis Medical) provide partial occlusion of the puncta with limited tear drainage for patients with moderate and severe dry eye. These plugs eliminate epiphora in patients for whom total occlusion is excessive.

Results from visual acuity testing, refraction, and corneal topography analysis using Scheimpflug imaging (Pentacam, Oculus) in a series of 48 eyes with progressive keratoconus demonstrate the benefits of corneal collagen crosslinking for halting keratoconus progression. More research is needed to provide answers to questions about the long-term stability of collagen corneal crosslinking and to refine its indications and contraindications.

The Joint Commission on Allied Health Personnel in Ophthalmology announced in a prepared statement that it has received approval for a separate occupational classification, ophthalmic medical technician, from the U.S. Bureau of Labor's 2010 Standard Occupational Classification committee.

Dyax Corp. and Fovea Pharmaceuticals have entered into an exclusive license agreement for the development and commercialization of an ocular formulation of DX-88 for the treatment of retinal diseases, the companies announced in a joint statement.

Ophthalmology is constantly evolving, and the ways things are done now are not necessarily going to stay the same in the future. The reality is that it's more important to be able to adapt to change than it is to predict change.

Analysts and ophthalmologists are closely watching the drama unfolding between private Swiss drugmaker Roche and the publicly traded, California-based Genentech, maker of ranibizumab (Lucentis), the only FDA-approved treatment for age-related macular degeneration (AMD), and its popular cousin, bevacizumab (Avastin). Roche is attempting a hostile takeover of Genentech.

This is the personal experience of electronic prescribing (e-prescribing) implementation presented by Cindy Maddox, MD, FACS, director of glaucoma services and vice chairwoman at the New England Eye Center, Tufts University School of Medicine, Boston and member of the American Academy of Ophthalmology's health policy committee.

Sightsavers International has launched the Mumbai Eye Care Campaign to prevent avoidable blindness and to offer eye care to millions of Mumbai's citizens in underserved areas of the city, such as Dharavi, the setting of the award-winning film, 'Slumdog Millionaire.'

The American Academy of Ophthalmology (AAO) recognized in a statement the passing of Yasuo Tano, MD, president of the Asia-Pacific Academy of Ophthalmology and immediate past president of the Japanese Ophthalmological Society.

Paul Bryar, MD, an ophthalmologist from Chicago, is running as a democratic candidate in the Illinois special primary election that will take place March 3, according to a release issued by the American Society of Cataract and Refractive Surgery.

A new formulation of lubricant eye drop (Systane Ultra, Alcon Laboratories) contains polymer network and demulcent ingredients that have been proven in multiple studies to provide benefits in patients with dry eye disease, according to one ophthalmologist. The drop, however, reformulates these agents in a system designed to further enhance ocular surface comfort, protection, and symptomatic relief. Initial patient impressions are very positive, he said.